Ensysce Biosciences Inc (ENSC)

Nov 15, 2024

Anson Funds Management LP Acquires New Stake in Ensysce Bioscien - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Ensysce Biosciences Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

This Is Why Ensysce Biosciences, Inc.'s (NASDAQ:ENSC) CEO Compensation Looks Appropriate - Simply Wall St

Nov 14, 2024

Nov 14, 2024

Comparing Ensysce Biosciences (NASDAQ:ENSC) and Kiniksa Pharmaceuticals (NASDAQ:KNSA) - Defense World

Nov 14, 2024

Nov 14, 2024

Ensysce Biosciences, Inc. (NASDAQ:ENSC) Short Interest Up 5,514.5% in October - Defense World

Nov 14, 2024

Nov 12, 2024

Ensysce Biosciences Reports Improved Financial Results - TipRanks

Nov 12, 2024

Nov 12, 2024

Ensysce Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Ensysce Biosciences Reports Third Quarter 2024 Financial Results - AccessWire

Nov 12, 2024

Nov 12, 2024

Ensysce Biosciences Secures $14M NIH Grant, Swings to Q3 Profit Amid Clinical Progress | ENSC Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Ensysce Biosciences granted Nasdaq listing extension By Investing.com - Investing.com Canada

Nov 08, 2024

Nov 07, 2024

Ensysce Biosciences granted Nasdaq listing extension - Investing.com

Nov 07, 2024

Nov 07, 2024

Ensysce Biosciences Receives Positive Nasdaq Listing Determination - AccessWire

Nov 07, 2024

Nov 07, 2024

Ensysce Biosciences Secures Critical Nasdaq Extension Through 2024 Amid Listing Challenges | ENSC Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

RA Capital Management, L.P. Acquires New Stake in Ensysce Biosci - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Ensysce Biosciences (NASDAQ:ENSC) Trading Down 9.8% – What’s Next? - Defense World

Nov 06, 2024

Nov 03, 2024

Ensysce Biosciences Presenting at Upcoming Meetings - GuruFocus.com

Nov 03, 2024

Oct 30, 2024

Perceptive Advisors LLC's Strategic Acquisition of Ensysce Biosc - GuruFocus.com

Oct 30, 2024

Oct 24, 2024

3 Penny Stocks to Watch Now, 10/24/24 - TipRanks

Oct 24, 2024

Oct 23, 2024

Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss - Benzinga

Oct 23, 2024

Oct 22, 2024

Regeneron Pharmaceuticals (REGN) Stock Drops Amid Market Volatility - GuruFocus.com

Oct 22, 2024

Oct 22, 2024

Advaxis (ADXS) Sees 112.96% Surge Amid Market Volatility - GuruFocus.com

Oct 22, 2024

Oct 22, 2024

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Oct 22, 2024

Oct 18, 2024

Ensysce Biosciences adjusts quorum requirement for stockholder meetings - Investing.com India

Oct 18, 2024

Oct 18, 2024

Ensysce Biosciences adjusts quorum requirement for stockholder meetings By Investing.com - Investing.com South Africa

Oct 18, 2024

Oct 16, 2024

When Will Ensysce Biosciences, Inc. (NASDAQ:ENSC) Breakeven? - Simply Wall St

Oct 16, 2024

Oct 16, 2024

Ensysce Biosciences Inc (ENSC) presents a great opportunity, but the stock is slightly undervalued - US Post News

Oct 16, 2024

Oct 15, 2024

ENSC’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Oct 15, 2024

Oct 15, 2024

Closing Figures: Ensysce Biosciences Inc (ENSC)’s Negative Finish at 0.17, Down -4.39 - The Dwinnex

Oct 15, 2024

Oct 09, 2024

Anchoring Your Portfolio: Is ENSC Stock a Safe Harbor? - The InvestChronicle

Oct 09, 2024

Oct 09, 2024

Ensysce Biosciences Inc (ENSC) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

Oct 09, 2024

Oct 09, 2024

Market Momentum: Ensysce Biosciences Inc (ENSC) Registers a -14.87 Decrease, Closing at 0.19 - The Dwinnex

Oct 09, 2024

Oct 08, 2024

ENSC stock touches 52-week low at $0.19 amid market challenges By Investing.com - Investing.com South Africa

Oct 08, 2024

Oct 08, 2024

ENSC stock touches 52-week low at $0.19 amid market challenges - Investing.com

Oct 08, 2024

Oct 08, 2024

Ensysce Biosciences Announces Leadership Team’s Participation in the Annual Pain Therapeutics Summit - StockTitan

Oct 08, 2024

Oct 02, 2024

Ensysce meets Nasdaq requirements, advances pain treatment - Investing.com

Oct 02, 2024

Oct 02, 2024

Ensysce meets Nasdaq requirements, advances pain treatment By Investing.com - Investing.com Canada

Oct 02, 2024

Oct 02, 2024

Ensysce Biosciences responds to recent shareholder inquiries - TipRanks

Oct 02, 2024

Oct 02, 2024

Ensysce Biosciences Provides Shareholder Update, Responds to Recent Shareholder Inquiries - AccessWire

Oct 02, 2024

Oct 02, 2024

Ensysce Biosciences Provides Shareholder Update, Responds to Recent Shareholder Inquiries | ENSC Stock News - StockTitan

Oct 02, 2024

Oct 01, 2024

ENSC stock touches 52-week low at $0.23 amid market challenges - Investing.com Canada

Oct 01, 2024

Oct 01, 2024

ENSC Stock Update: Ensysce Biosciences Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Oct 01, 2024

Oct 01, 2024

Ratio Analysis: Unpacking Ensysce Biosciences Inc (ENSC)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 01, 2024

Sep 28, 2024

Ensysce Biosciences faces Nasdaq delisting over noncompliance By Investing.com - Investing.com Australia

Sep 28, 2024

Sep 27, 2024

Ensysce Biosciences faces Nasdaq delisting over noncompliance - Investing.com

Sep 27, 2024

Sep 27, 2024

Ensysce Biosciences (NASDAQ:ENSC) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024

Sep 27, 2024

Ensysce Biosciences Receives Notice from Nasdaq - AccessWire

Sep 27, 2024

Sep 25, 2024

Ensysce Biosciences, Inc. (NASDAQ:ENSC) Short Interest Update - Defense World

Sep 25, 2024

Sep 24, 2024

Ensysce Biosciences Presenting at Upcoming Meetings | ENSC Stock News - StockTitan

Sep 24, 2024

Sep 23, 2024

ENSC stock touches 52-week low at $0.31 amid market challenges - Investing.com Canada

Sep 23, 2024

Sep 20, 2024

Ensysce Biosciences submits Phase 3 study protocol for pain treatment - Investing.com

Sep 20, 2024